Featured Posts
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Search Posts
Newsletter
Net Neutrality, Poultry Wars and Disaster Insurance
The House Telecommunications and Internet Subcommittee holds a hearing on proposed rules for “net neutrality.” The European Union refuses to lift a ban on the…
Citation
Too Fat to Fire?
Newsletter
Baby Bottles, Union Conflicts and Credit Card Fees
Wal-Mart announces that it will stop selling baby bottles made with the chemical bisphenol A, or BPA. Members of the California Nurses Association and the…
Newsletter
Environmental Politics, Internet Gambling and Drug Imports
Regnery Publishing releases the new book The Really Inconvenient Truths: Seven Environmental Catastrophes Liberals Don't Want You to Know About--Because They Helped Cause Them. An…
Op-Eds
Anatomy of a Chemical Murder
Wal-Mart announced last week that it would stop selling baby bottles made with the chemical bisphenol A, or BPA.
News Release
Are Imports the Solution to High Drug Prices?
With the high cost of pharmaceutical drugs playing a central role in the national debate over health care, many policymakers have endorsed the idea…